Amgen (AMGN) stock price, revenue, and financials

Amgen market cap is $140.6 b, and annual revenue was $25.42 b in FY 2020

$140.6 B

AMGN Mkt cap, 22-Jul-2021

$5.9 B

Amgen Revenue Q1, 2021
Amgen Gross profit (Q1, 2021)4.4 B
Amgen Gross profit margin (Q1, 2021), %74.8%
Amgen Net income (Q1, 2021)1.6 B
Amgen EBIT (Q1, 2021)2.1 B
Amgen Cash, 31-Mar-20216.1 B
Amgen EV167.2 B
Get notified regarding key financial metrics and revenue changes at AmgenLearn more
Banner background

Amgen Revenue

Amgen revenue was $25.42 b in FY, 2020 which is a 8.8% year over year increase from the previous period.

Embed Graph

Amgen Revenue Breakdown

Embed Graph

Amgen revenue breakdown by business segment: 8.6% from Otezla, 19.7% from Enbrel, 9.0% from Neulasta, 10.9% from Prolia, 7.5% from XGEVA, 6.2% from Aranesp, 25.9% from Other Products and 12.3% from Other

Amgen revenue breakdown by geographic segment: 72.8% from United States and 27.2% from Rest of World

Amgen Income Statement

Annual

USDFY, 2018FY, 2019FY, 2020

Revenue

23.7b23.4b25.4b

Revenue growth, %

4%(2%)9%

Cost of goods sold

4.1b4.4b6.2b

Gross profit

19.6b19.0b19.3b

Gross profit Margin, %

83%81%76%

R&D expense

3.7b4.1b4.2b

General and administrative expense

5.3b5.2b5.7b

Operating expense total

9.4b9.3b10.1b

EBIT

10.3b9.7b9.1b

EBIT margin, %

43%41%36%

Interest expense

1.4b1.3b1.3b

Pre tax profit

9.5b9.1b8.1b

Income tax expense

1.2b1.3b869.0m

Net Income

8.4b7.8b7.3b

EPS

12.612.912.3

Quarterly

Amgen Balance Sheet

Annual

USDFY, 2018FY, 2019FY, 2020

Cash

6.9b6.0b6.3b

Accounts Receivable

3.6b4.1b4.5b

Inventories

2.9b3.6b3.9b

Current Assets

37.6b18.4b21.1b

PP&E

5.0b4.9b4.9b

Goodwill

14.7b14.7b14.7b

Total Assets

66.4b59.7b62.9b

Accounts Payable

1.2b1.4b1.4b

Short-term debt

4.4b3.0b91.0m

Current Liabilities

13.5b12.8b11.7b

Long-term debt

29.5b27.0b32.9b

Total Debt

33.9b29.9b33.0b

Common Stock

578.3m

Additional Paid-in Capital

31.2b31.5b31.8b

Retained Earnings

(18.0b)(21.3b)(21.4b)

Total Equity

12.5b9.7b9.4b

Debt to Equity Ratio

2.7 x3.1 x3.5 x

Debt to Assets Ratio

0.5 x0.5 x0.5 x

Financial Leverage

5.3 x6.2 x6.7 x

Amgen Cash Flow

Annual

USDFY, 2018FY, 2019FY, 2020

Net Income

8.4b7.8b7.3b

Depreciation and Amortization

1.9b2.2b3.6b

Accounts Receivable

(378.0m)(504.0m)(427.0m)

Inventories

(3.0m)(66.0m)(215.0m)

Accounts Payable

(143.0m)164.0m45.0m

Cash From Operating Activities

11.3b9.2b10.5b

Purchases of PP&E

(738.0m)(618.0m)(608.0m)

Cash From Investing Activities

14.3b5.7b(5.4b)

Long-term Borrowings

(1.1b)(4.5b)(6.4b)

Dividends Paid

(3.5b)(3.5b)(3.8b)

Cash From Financing Activities

(22.5b)(15.8b)(4.9b)

Net Change in Cash

3.1b(908.0m)229.0m

Amgen Ratios

USDFY, 2018

EV/EBIT

14.6 x

EV/CFO

13.2 x

Revenue/Employee

1.1m

Debt/Equity

2.7 x

Debt/Assets

0.5 x

Financial Leverage

5.3 x

P/E Ratio

15.4

Amgen Operating Metrics

FY, 2018FY, 2019FY, 2020

Administrative Facilities (Foreign)

131313

Administrative Facilities (US)

455

Countries

100100100

Distribution Centers (Foreign)

333

Distribution Centers (US)

333

Facilities

190190180

Manufacturing Facilities (Foreign)

555

Manufacturing Facilities (US)

444

Patents (EU)

152121

Patents (US)

273431

Phase I Trials Products

222220

Phase II Trials Products

345

Phase III Trials Products

71011

Research and Development Centers (Foreign)

776

Research and Development Centers (US)

333

Sales and Marketing Locations (Foreign)

111112

Sales and Marketing Locations (US)

222

Warehouses (Foreign)

666

Warehouses (US)

555

Amgen Sustainability Metrics

 FY, 2019

Water Withdrawn

2.15 m cubic meters

Water Recycled

548 k cubic meters

Waste Recycled

3.75 k metric tons

Waste Generated

9.82 k metric tons

Notices of Violations

2

Lost Time Injury Frequency Rate

0.6

Energy Used (Renewables)

480 k GJ

Energy Used (Propane)

1.2 k GJ

Energy Used (Nuclear)

96 k GJ

Energy Used (Natural Gas)

1.01 m GJ

Energy Used (Fossil Fuels)

894 k GJ

Energy Used (Diesel)

533 k GJ

Energy Used

3.28 m GJ

Carbon Emissions

249 k metric tons of carbon dioxide equivalent

Amgen Human Capital

FY, 2020FY, 2019FY, 2018
Male (Craft Workers, USA), percent7.9%
Male (Service Workers, USA), percent6.7%
Male (Operatives, USA), percent7.4%
Male (Technicians, USA), percent6.1%
Female (Administrative Support, USA), percent7.9%
Other64%
Male, percent24%48%
Female, percent26%52%
Male (Executive Management), percent30.5%
Female (Executive Management), percent19.5%

Ethnicity

FY, 2020FY, 2019FY, 2018
Ethnic Minorities (USA), percent12.1%24%35%
White (USA), percent15.6%
Ethnic Non-Minorities (Executive Management, USA), percent17.7%36%
Ethnic Minorities (Executive Management, USA), percent7.6%14%
Non-Minorities (Management, USA), percent14.6%
Minorities (Management, USA), percent10.6%
Ethnic Non-Minorities (USA), percent 13.1%26%65%
Other8.8%

Amgen Employee Rating

42913 votes
Culture & Values
3.8
Work/Life Balance
3.6
Senior Management
3.4
Salary & Benefits
4.1
Career Opportunities
3.5
Source